SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001387131-20-006322
Filing Date
2020-07-10
Accepted
2020-07-10 17:26:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D crsp-sc13da_070620.htm SC 13D/A 89915
  Complete submission text file 0001387131-20-006322.txt   91418
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89674 | Film No.: 201023862
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences